Acne Vulgaris
📧 Sign up to get email alerts when something new happens for Acne Vulgaris.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-08-23FDA Approved: AMNESTEEM — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for AMNESTEEM (isotretinoin) filed by Mylan Pharmaceuticals Inc. The document indicates an appro…
-
FDA approval · 2022-08-23FDA Approved: ZENATANE — Supplemental Application (BluePoint Laboratories)
FDA approves a supplemental application for ZENATANE (isotretinoin) filed by BluePoint Laboratories.
-
FDA approval · 2022-08-04FDA Approved: ZENATANE — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for Zenatane (isotretinoin) by BluePoint Laboratories.
-
FDA approval · 2022-08-04FDA Approved: ADAPALENE AND BENZOYL PEROXIDE — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals' original application for Adapalene and benzoyl peroxide topical for acne vulgaris.
-
CLINICAL_TRIALS trial_result · 2022-07-29Clinical Trial Update: Differin® Gel x12 Wks vs Tazorac® Cream x12 Wks vs Differin® x6 Wks Switched to Tazorac® x6 Wks for Treatment of Acne [Phase 4]
Phase 4 trial comparing Differin Gel over 12 weeks and Tazorac Cream over 12 weeks, with a 6-week Differin-to-Tazorac switch, in acne vulgar…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-07-29Clinical Trial Update: Analysis of Adherence & Associated Factors in Teenagers Undergoing Treatment of Acne Vulgaris With Differin® Gel 0.1% [Phase 4]
Phase 4 clinical trial update analyzing adherence and associated factors in teenagers using Differin Gel 0.1% for acne vulgaris.
-
CLINICAL_TRIALS trial_result · 2022-07-27Clinical Trial Update: Aczone Gel 7.5% in the Treatment of Acne Vulgaris in Patients With Skin of Color [Phase 4]
Phase 4 clinical trial update evaluating Aczone Gel 7.5% for acne vulgaris in patients with skin of color has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-07-26Clinical Trial Update: Open Label Photo-Documentation Study Of BPX-01 Minocycline Gel [Phase 2]
Open-label Phase 2 trial of BPX-01 minocycline gel for acne vulgaris has completed with results posted.
-
FDA approval · 2022-07-19FDA Approved: AKLIEF — Supplemental Application (Galderma Laboratories, L.P.)
This FDA document concerns a supplemental application for AKLIEF (trifarotene) submitted by Galderma Laboratories, L.P.
-
FDA approval · 2022-07-01FDA Approved: AZELAIC ACID GEL — Supplemental Application (Encube Ethicals, Inc.)
FDA approved a supplemental application for AZELAIC ACID GEL from Encube Ethicals, Inc. under ANDA208724.
-
FDA approval · 2022-06-22FDA Approved: ADAPALENE AND BENZOYL PEROXIDE — Original Application (Teva Pharmaceuticals, Inc.)
FDA approved Teva's Original Application for a generic adapalene with benzoyl peroxide topical acne treatment. It provides a generic option …
-
FDA approval · 2022-06-14FDA Approved: DIFFERIN — Supplemental Application (Galderma Laboratories, L.P.)
FDA approved a supplemental application for Differin (adapalene) filed by Galderma Laboratories, L.P.
-
FDA approval · 2022-06-03FDA Approved: ADAPALENE AND BENZOYL PEROXIDE — Original Application (Zydus Lifesciences Limited)
FDA approved the original ANDA for a generic combination of adapalene and benzoyl peroxide from Zydus Lifesciences Limited for acne vulgaris…
-
FDA approval · 2022-05-31FDA Approved: ADAPALENE AND BENZOYL PEROXIDE — Original Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a new original application for a topical combination of adapalene and benzoyl peroxide for acne vulgaris, developed by Padagis …
-
CLINICAL_TRIALS trial_result · 2022-05-10Clinical Trial Update: A Study to Compare Efficacy and Safety of Trifarotene Cream When Used With an Oral Antibiotic for the Treatment of Severe Acne Vulgaris (AV) [Phase 4]
A Phase 4 trial evaluating the efficacy and safety of trifarotene cream in combination with an oral antibiotic for severe acne vulgaris has …
-
CLINICAL_TRIALS trial_result · 2022-05-09Clinical Trial Update: Weekly Isotretinoin Therapy Study [Phase 1, Phase 2]
Phase 1/2 clinical trial on weekly isotretinoin therapy for acne vulgaris has completed with results posted.
-
FDA approval · 2022-04-27FDA Approved: EPIDUO FORTE — Supplemental Application (Galderma Laboratories, L.P.)
FDA approved a supplemental application for Epiduo Forte (adapalene and benzoyl peroxide) by Galderma Laboratories, L.P.
-
CLINICAL_TRIALS trial_result · 2022-04-18Clinical Trial Update: Evaluation of BTX 1503 in Patients With Moderate to Severe Acne Vulgaris [Phase 2]
Phase 2 clinical trial update for BTX 1503 in moderate to severe acne vulgaris has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-04-13Clinical Trial Update: Effects of Oral Zinc Gluconate Among Acne Vulgaris Patients [Phase 4]
A Phase 4 clinical trial evaluating the effects of oral zinc gluconate in patients with acne vulgaris has completed with posted results.
-
FDA approval · 2022-04-07FDA Approved: ABSORICA LD — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approves a supplemental application for ABSORICA LD (isotretinoin) from Sun Pharmaceutical Industries, Inc. This action approves a suppl…
-
CLINICAL_TRIALS trial_result · 2022-04-07Clinical Trial Update: Impact of Isotretinoin in Different Doses on Quality of Life [Phase 4]
Phase 4 trial evaluating how different isotretinoin doses affect quality of life in acne vulgaris.
-
CLINICAL_TRIALS trial_result · 2022-04-01Clinical Trial Update: DAPSONE GEL7.5%Versus Trichloroacetic Acid 20% ON ACNE VULGARIS [Phase 4]
A Phase 4 trial comparing dapsones gel 7.5% to trichloroacetic acid 20% in acne vulgaris.
-
CLINICAL_TRIALS trial_result · 2022-03-21Clinical Trial Update: Effectiveness of Zinc Supplementation With Topical Retinoids in Acne Vulgaris Patients [Phase 2]
Phase 2 trial updating the effectiveness of zinc supplementation combined with topical retinoids for acne vulgaris.
-
FDA label_change · 2022-03-18FDA Approved: WINLEVI — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for WINLEVI (clascoterone) from Sun Pharmaceutical Industries, updating the product labeling.
-
FDA approval · 2022-02-10FDA Approved: CLINDAMYCIN PHOSPHATE AND TRETINOIN — Original Application (Solaris Pharma Corporation)
The FDA approved Solaris Pharma Corporation's clindamycin phosphate and tretinoin as an original application, a topical combination product …